MedCap AB (publ)

Research MedCap AB (publ) (MCAP) on Bullrun: valuation model: 8.4% overvalued, market cap SEK 7.66B, P/E 31.8. Explore financials, valuation history, model signals, and stock context.

Key Metrics

TickerMCAP
ExchangeST
CountrySweden
SectorHealthcare
IndustryMedical Devices
CurrencySEK
Valuation signal8.4% overvalued
Market capSEK 7.66B
P/E31.8
Financial periodQ2 2026
RevenueSEK 606.30M
Net incomeSEK 69.10M
Free cash flowSEK 107.70M
Gross margin59.8%

Valuation Snapshot

Bullrun's latest valuation model marks MedCap AB (publ) as 8.4% overvalued; latest market cap is SEK 7.66B; P/E is 31.8.

Peer valuation comparison

Latest P/E is 31.75x versus a Healthcare sector median of 24.61x (29.0% above).

Latest P/E is 31.75x versus a Sweden median of 18.18x (74.6% above).

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2025	SEK 2.12B	SEK 219.90M	n/a	58.6%	n/a	SEK 370.40M	SEK 482.90M	SEK 1.45B
FY2024	SEK 1.83B	SEK 207.30M	n/a	58.6%	n/a	SEK 370.10M	SEK 358.00M	SEK 1.28B
FY2023	SEK 1.61B	SEK 172.10M	n/a	58.4%	n/a	SEK 188.20M	n/a	n/a
FY2022	SEK 1.15B	SEK 117.50M	n/a	61.3%	n/a	SEK 236.20M	n/a	n/a

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-04	SEK 7.66B	31.8	n/a	0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 SEK.

About MedCap AB (publ)

MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, and buyout. It prefers to invest in Biotechnology; Life sciences; Pharmaceuticals; MedTech including healthcare equipment, software, components, and packaging solutions for life science products;

Related stock research

Sweden stocks Sweden Healthcare stocks A-Z stock index

Other Healthcare stocks

Acarix A/S (ACARIX) Arcoma AB (ARCOMA) Bactiguard Holding AB (publ) (BACTI-B) BiBBInstruments AB (BIBB.ST) BICO Group AB (BICO) Boule Diagnostics AB (BOUL) BrainCool AB (BRAIN) CellaVision AB (CEVI) Clinical Laserthermia Systems AB (publ) (CLS-B) C-Rad AB (publ) (CRAD-B) Devyser Diagnostics AB (DVYSR) Elekta AB (publ) (EKTA-B)

Frequently asked questions

Is MedCap AB (publ) overvalued or undervalued?

Bullrun's valuation model currently marks MedCap AB (publ) as 8.4% overvalued.

What is MedCap AB (publ)'s market cap?

MedCap AB (publ)'s market capitalization is SEK 7.66B.

What is MedCap AB (publ)'s P/E ratio?

MedCap AB (publ)'s price-to-earnings (P/E) ratio is 31.8.